Close Menu

NEW YORK (GenomeWeb) – Continuing the climb it began in April, the GenomeWeb Index outperformed the broader stock market in May, gaining more than 7 percent.

The Index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which gained 1 percent, 5 percent, and 5 percent, respectively. Stock performance in the May GenomeWeb Index was largely positive, as 20 of the 26 stocks saw gains and only six saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.